Anna Ferrari

14PUBLICATIONS
47CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 24, 2026
Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

|Sep 27, 2025
Unveiling Cryptic BCR-ABL1 Rearrangements: Diagnostic Challenges and Clinical Impact in Myeloid Malignancies.

Anna Ferrari, Chiara Salvesi, Eugenio Fonzi

|Nov 26, 2024
Exploring the role of PARP1 inhibition in enhancing antibody-drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions.

Andrea Ghelli Luserna di Rorà, Mouna Jandoubi, Antonella Padella

|Jan 11, 2024
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.

Maria Teresa Bochicchio, Giovanni Marconi, Carmen Baldazzi

|Jun 29, 2023
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.

Laura Mazzera, Manuela Abeltino, Guerino Lombardi

|Apr 28, 2023
Detection of a Novel MSI2-C17orf64 Transcript in a Patient with Aggressive Adenocarcinoma of the Gastroesophageal Junction: A Case Report.

Anna Ferrari, Roberto Fiocca, Elena Bonora

Pageof 3

Frequent Collaborators

8 joint publications

Michela Rondoni

5 joint publications

Eugenio Fonzi

5 joint publications

Giorgia Simonetti

3 joint publications

Antonella Padella